These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
157 related articles for article (PubMed ID: 1516031)
1. Prognostic factors. Stage and receptor status in breast cancer. Donegan WL Cancer; 1992 Sep; 70(6 Suppl):1755-64. PubMed ID: 1516031 [TBL] [Abstract][Full Text] [Related]
2. Absent progesterone receptor expression in the lymph node metastases of ER-positive, HER2-negative breast cancer is associated with relapse on tamoxifen. Snell CE; Gough M; Middleton K; Hsieh M; Furnas L; Seidl B; Gibbons K; Pyke C; Shannon C; Woodward N; Armes JE J Clin Pathol; 2017 Nov; 70(11):954-960. PubMed ID: 28416639 [TBL] [Abstract][Full Text] [Related]
3. Prediction of recurrence for advanced breast cancer. Traditional and contemporary pathologic and molecular markers. Masood S Surg Oncol Clin N Am; 1995 Oct; 4(4):601-32. PubMed ID: 8535901 [TBL] [Abstract][Full Text] [Related]
4. Prognostic significance of steroid hormone receptors and histopathological characterization of human breast cancer. Reiner A; Kolb R; Reiner G; Jakesz R; Schemper M; Spona J J Cancer Res Clin Oncol; 1987; 113(3):285-90. PubMed ID: 3584218 [TBL] [Abstract][Full Text] [Related]
5. [Clinicopathological features and prognostic factors of breast cancer patients with inguinal lymph node metastases: a report of 17 cases]. Li Q; Xu BH; Zhang P; Li Q; Yuan P; Wang JY; Luo Y; Ma F; Fan Y; Li Q Zhonghua Zhong Liu Za Zhi; 2013 Mar; 35(3):207-11. PubMed ID: 23880002 [TBL] [Abstract][Full Text] [Related]
6. [Prognostic factors in breast cancer--classification in non-university hospitals]. Willner J; Kiricuta IC; Kölbl O; Bohndorf W Zentralbl Chir; 1993; 118(9):525-31. PubMed ID: 8237148 [TBL] [Abstract][Full Text] [Related]
7. Prognostic significances of estrogen and progesterone receptors in primary operable breast cancer. Kurebayashi J; Ishida T; Higashi Y; Suemasu K; Nomoto C; Yoshida K Jpn J Clin Oncol; 1990 Sep; 20(3):271-80. PubMed ID: 2255103 [TBL] [Abstract][Full Text] [Related]
8. [The effect of axillary lymph node status on the prognosis of patients with local-regional recurrence after breast-conserving surgery]. Zhang Z; Zhang W; Li ZJ; Wang XM; Cao XC; Xiao CH Zhonghua Zhong Liu Za Zhi; 2018 May; 40(5):347-351. PubMed ID: 29860761 [No Abstract] [Full Text] [Related]
9. Correlation of DNA flow cytometry and hormone receptors with axillary lymph node status in patients with carcinoma of the breast. Friedman NS; Freedman MD Md Med J; 1994 Nov; 43(11):963-5. PubMed ID: 7808198 [TBL] [Abstract][Full Text] [Related]
10. [Evidence-based radiotherapy in the treatment of early-stage invasive breast cancer: traditional clinical features and biomarkers]. Fodor J Magy Onkol; 2009 Mar; 53(1):7-14. PubMed ID: 19318321 [TBL] [Abstract][Full Text] [Related]
11. LEA-135 expression: its association with a lower risk of recurrence and increased overall survival of patients with lymph node-positive primary invasive breast cancer. Saha B; Zhang N; Naritoku WY; Tsao-Wei DD; Groshen SL; Carlsson G; Larsson L; Gustavsson B; Chaiwun B; Taylor CR; Imam SA Anticancer Res; 2004; 24(4):2391-400. PubMed ID: 15330189 [TBL] [Abstract][Full Text] [Related]
12. Impact of the 21-gene recurrence score assay compared with standard clinicopathologic guidelines in adjuvant therapy selection for node-negative, estrogen receptor-positive breast cancer. Partin JF; Mamounas EP Ann Surg Oncol; 2011 Nov; 18(12):3399-406. PubMed ID: 21537874 [TBL] [Abstract][Full Text] [Related]
13. Metastatic axillary lymph node ratio (LNR) is prognostically superior to pN staging in patients with breast cancer--results for 804 Chinese patients from a single institution. Xiao XS; Tang HL; Xie XH; Li LS; Kong YN; Wu MQ; Yang L; Gao J; Wei WD; Xie X Asian Pac J Cancer Prev; 2013; 14(9):5219-23. PubMed ID: 24175804 [TBL] [Abstract][Full Text] [Related]
14. Relationship of presence of progesterone receptors to prognosis in early breast cancer. Pichon MF; Pallud C; Brunet M; Milgrom E Cancer Res; 1980 Sep; 40(9):3357-60. PubMed ID: 7427948 [TBL] [Abstract][Full Text] [Related]
15. [Prognostic factors in medullary breast cancer]. Mitze M; Goepel E Geburtshilfe Frauenheilkd; 1989 Jul; 49(7):635-41. PubMed ID: 2777051 [TBL] [Abstract][Full Text] [Related]
16. Biologic and clinicopathologic factors as indicators of specific relapse types in node-negative breast cancer. Silvestrini R; Daidone MG; Luisi A; Boracchi P; Mezzetti M; Di Fronzo G; Andreola S; Salvadori B; Veronesi U J Clin Oncol; 1995 Mar; 13(3):697-704. PubMed ID: 7884430 [TBL] [Abstract][Full Text] [Related]
17. Prediction of axillary lymph node status of breast cancer patients by tumorbiological factors of the primary tumor. Fehm T; Maul H; Gebauer S; Scharf A; Baier P; Sohn C; Jäger W; Gebauer G Strahlenther Onkol; 2005 Sep; 181(9):580-6. PubMed ID: 16170485 [TBL] [Abstract][Full Text] [Related]
18. [Flow cytophotometry parameters, hormone receptors and axillary lymph node status as prognostic factors in primary breast cancer]. Kaufmann M; Feichter GE; Nhila A; Klinga K; Abel U Geburtshilfe Frauenheilkd; 1988 Oct; 48(10):705-9. PubMed ID: 3234702 [TBL] [Abstract][Full Text] [Related]
19. Relative importance of estrogen and progesterone receptor assays as prognostic indicators in primary breast cancer: a short-term study. Brocklehurst D; Wilde CE; Finbow JA; Brett R; Champion AE; Dewhurst DG Clin Chem; 1989 Feb; 35(2):238-40. PubMed ID: 2914367 [TBL] [Abstract][Full Text] [Related]
20. Prognostic indicators in node-negative early stage breast cancer. Wong WW; Vijayakumar S; Weichselbaum RR Am J Med; 1992 May; 92(5):539-48. PubMed ID: 1580300 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]